Yıl: 2018 Cilt: 16 Sayı: 2 Sayfa Aralığı: 127 - 194 Metin Dili: Türkçe İndeks Tarihi: 22-07-2019

D Vitamini Ve Metabolomik

Öz:
D vitamini, kemik sağlığındaki önemli rolünün yanı sıra diyabet, kanser ve kardiyovasküler hastalıklargibi pek çok hastalık ile bağlantısı olan ve günümüzde hormon olarak kabul edilen bir moleküldür. Dvitamini düzeyinin değerlendirilmesinde, uzun bir yarı ömre sahip olduğundan 25-hidroksivitamin D[25(OH)D] tercih edilmektedir. Ancak D vitamini metabolitlerinin çeşitli hastalıklardaki patofizyolojikrolünü değerlendirmek için tüm metabolomun incelenmesi gerekmektedir. Bunun için total 25 (OH) Ddüzeylerinin yanı sıra serbest/biyoyararlanılabilir formlar, D vitamini bağlayıcı protein (DBP),parathormon ve 1, 25 (OH) 2 D3, 3-epi-25 (OH) D, 24,25 (OH) 2 D3 gibi diğer belirteçleri içerenmetabolomik bir panele gereksinim vardır. Gelecekte D vitamini metabolomiğinin kapsamlı bir şekildeincelenmesi için kütle spektrometreleri potansiyel vaat etmektedir.
Anahtar Kelime:

Konular: Biyoteknoloji ve Uygulamalı Mikrobiyoloji Biyokimya ve Moleküler Biyoloji

Metabolomics Approach in Vitamin D

Öz:
Vitamin D is a molecule, now seen as a hormone, it plays an important role in bone health, it is also associated with many diseases, such as diabetes, cancer and cardiovascular problems. 25- hydroxyvitamin D [25(OH)D] is used to estimate vitamin D status because its long half-life. However, to understand the pathophysiological role of vitamin D metabolites on various diseases, we need to evaluate all relevant metabolome. For this reason, a metabolomic panel is required to evaluate the vitamin D status that measurement of 25 (OH) D and other vitamin D biomarkers, e.g., 1α,25 (OH)2 D3 , 3-epi-25 (OH) D, 24,25 (OH)2 D3, vitamin D binding protein (DBP), free/bioavailable 25 (OH) D and parathyroid hormone. Mass spectrometers are promising for comprehensive analysis of vitamin D metabolites in the future.
Anahtar Kelime:

Konular: Biyoteknoloji ve Uygulamalı Mikrobiyoloji Biyokimya ve Moleküler Biyoloji
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • Müller MJ, Volmer DA, Mass Spectrometric Profiling of Vitamin D Metabolites beyond 25-Hydroxyvitamin D. Clin Chem 2015;61(8):1033-1048.
  • Prosser DE, Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trend Biochem Sci 2004;29:664 –73.
  • Bartoszewicz Z, Kondracka A, Jazwiec R, Popow M, Dadlez M, Bednarczuk T. Can we accurately measure the concentration of clinically relevant vitamin D metabolites in the circulation? The problems and their consequences. Endokrynol Pol 2013;64:238 – 45.
  • Bouillon R. The vitamin. The vitamin D binding protein DBP. In: D, Feldman JW, Pike JS, Adams, editors. Vitamin D. 3rd ed. London: Academic Press; 2011. p 57–72.
  • Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011;96:53–58.
  • Saleh L, Tang J, Gawinecka J, Boesch L, Fraser WD, Eckardstein A, Nowak A. Impact of a single oral dose of 100,000 IU vitamin D3 on profiles of serum 25(OH)D3 and its metabolites 24,25(OH)2D3, 3-epi25(OH)D3, and 1,25(OH)2D3 in adults with vitamin D insufficiency. Clin Chem Lab Med 2017; 55(12): 1912–1921.
  • Lehmann U, Hirche F, Stangl GI, Hinz K, Westphal S, Dierkes J. Bioavailability of Vitamin D2 and D3 in Healthy Volunteers, a Randomized PlaceboControlled Trial. J Clin Endocrinol Metab 2013, 98(11):4339–4345.
  • ripkovic L, Lambert H, Hart K, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitaminD status: a systematic review and meta-analysis. Am J Clin Nutr 2012;95:1357–1364.
  • Bailey D, Veljkovic K, Yazdanpanah M, Adeli K. Analytical measurement and clinical relevance of vitamin D(3) C3-epimer. Clin Biochem 2013;46: 190–6.
  • Heijboer AC, Blankenstein MA, Kema IP, Buijs MM. Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration. Clin Chem 2012;58:543– 8.
  • El-Khoury JM, Reineks EZ, Wang S. Progress of liquid chromatography-mass spectrometry in measurement of vitamin D metabolites and analogues. Clin Biochem 2011;44:66 –76.
  • Volmer DA, Mendes LR, Stokes CS. Analysis of vitamin D metabolic markers by mass spectrometry: current techniques, limitations of the “gold standard” method, and anticipated future directions. Mass Spectrom Rev 2015;34:2–23.
  • Gathungu RM, Flarakos CC, Satyanarayana Reddy G, Vouros P. The role of mass spectrometry in the analysis of vitamin D compounds. Mass Spectrom Rev 2013;32: 72– 86.
  • Zerwekh JE. Blood biomarkers of vitamin D status. Am J Clin Nutr. 2008;87(4):1087S–91S.
  • Herrmann M, Farrell CJL, Pusceddu I, FabregatCabello N, Cavalier E. Assessment of vitamin D status – a changing landscape. Clin Chem Lab Med 2017; 55(1): 3–26.
  • Stepman HC, Vanderroost A, Van Uytfanghe K, Thienpont LM. Candidate reference measurement procedures for serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 by using isotope-dilution liquid chromatography-tandem mass spectrometry. Clin Chem. 2011;57(3):441– 8.
  • Farrell C-JL, Martin S, McWhinney B, Straub I, Williams P, Herrmann M. State-of-the-Art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clin Chem. 2012;58(3):531– 42
  • Couchman L, Benton CM, Moniz CF. Variability in the analysis of 25-hydroxyvitamin D by liquid chromatography-tandem mass spectrometry: the devil is in the detail. Clin Chim Acta. 2012;413(15– 16):1239–43.
  • Ouweland JM, Vogeser M, Bächer S, Vitamin D and metabolites measurement by tandem mass spectrometry. Rev Endocr Metab Disord. 2013; 14:159–184.
  • Knox S, Harris J, Calton L, Wallace AM. A simple automated solid-phase extraction procedure for measurement of 25-hydroxyvitamin D3 and D2 by liquid chromatography-tandem mass spectrometry. Ann Clin Biochem. 2009;46(Pt 3):226–30.
  • Strathmann FG, Laha TJ, Hoofnagle AN. Quantification of 1alpha,25-dihydroxy vitamin D by immunoextraction and liquid chromatographytandem mass spectrometry. Clin Chem. 2011;57(9):1279–85.
  • Casetta B, Jans I, Billen J, Vanderschueren D, Bouillon R. Development of a method for the quantification of 1alpha,25(OH)2-vitamin D3 in serum by liquid chromatography tandem mass spectrometry without derivatization. Eur J Mass Spectrom (Chichester, Eng). 2010;16(1):81–9.
  • Aronov PA, Hall LM, Dettmer K, Stephensen CB, Hammock BD. Metabolic profiling of major vitamin D metabolites using Diels-Alder derivatization and ultra-performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2008;391(5):1917–30.
  • Wang Z, Senn T, Kalhorn T, Zheng XE, Zheng S, Davis CL, et al. Simultaneous measurement of plasma vitamin D(3) metabolites, including 4beta,25-dihydroxyvitamin D(3), using liquid chromatography-tandem mass spectrometry. Anal Biochem. 2011;418(1):126-33.
  • Hedman CJ, Wiebe DA, Dey S, Plath J, Kemnitz JW, Ziegler TE, Development of a sensitive LC/MS/MS method for vitamin D metabolites: 1,25 Dihydroxyvitamin D2&3 measurement using a novel derivatization agent. J Chromatogr B Analyt Technol Biomed Life Sci. 2014; 953-954:62-67.
  • Yuan C, Kosewick J, He X, Kozak M, Wang S, Sensitive measurement of serum 1α,25- dihydroxyvitamin D by liquid chromatography/ tandem mass spectrometry after removing interference with immunoaffinity extraction. Rapid Commun. Mass Spectrom. 2011, 25(9):1241–1249.
  • Karatoy Erdem B, Yilmaz VT, Suleymanlar G, Ozcan F, Baykal Ataman A, Akbas H, The relationship between vitamin D status and graft function in renal transplant recipients. Int J Med Biochem 2018;1(1):1-5.
  • Kamao M, Tatematsu S, Hatakeyama S, Sakaki T, Sawada N, Inouye K, et al. C-3 epimerization of vitamin D3 metabolites and further metabolism of C-3 epimers. J Biol Chem. 2004;279(16):15897– 907.
  • Singh RJ, Taylor RL, Reddy GS, Grebe SK. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab. 2006;91(8):3055–61.
  • Lensmeyer G, Poquette M, Wiebe D, Binkley N. The C-3 epimer of 25-hydroxyvitamin D(3) is present in adult serum. J Clin Endocrinol Metab. 2012; 97(1):163-8.
  • Sempos CT, Vesper HW, Phinney KW, Thienpont LM, Coates PM. Vitamin D status as an international issue: national surveys and the problem of standardization. Scand J Clin Lab Invest Suppl. 2012; 243:32–40.
APA Karatoy Erdem B, AKBAŞ S (2018). D Vitamini Ve Metabolomik. , 127 - 194.
Chicago Karatoy Erdem Bilge,AKBAŞ SADIKA HALİDE D Vitamini Ve Metabolomik. (2018): 127 - 194.
MLA Karatoy Erdem Bilge,AKBAŞ SADIKA HALİDE D Vitamini Ve Metabolomik. , 2018, ss.127 - 194.
AMA Karatoy Erdem B,AKBAŞ S D Vitamini Ve Metabolomik. . 2018; 127 - 194.
Vancouver Karatoy Erdem B,AKBAŞ S D Vitamini Ve Metabolomik. . 2018; 127 - 194.
IEEE Karatoy Erdem B,AKBAŞ S "D Vitamini Ve Metabolomik." , ss.127 - 194, 2018.
ISNAD Karatoy Erdem, Bilge - AKBAŞ, SADIKA HALİDE. "D Vitamini Ve Metabolomik". (2018), 127-194.
APA Karatoy Erdem B, AKBAŞ S (2018). D Vitamini Ve Metabolomik. Türk Klinik Biyokimya Dergisi, 16(2), 127 - 194.
Chicago Karatoy Erdem Bilge,AKBAŞ SADIKA HALİDE D Vitamini Ve Metabolomik. Türk Klinik Biyokimya Dergisi 16, no.2 (2018): 127 - 194.
MLA Karatoy Erdem Bilge,AKBAŞ SADIKA HALİDE D Vitamini Ve Metabolomik. Türk Klinik Biyokimya Dergisi, vol.16, no.2, 2018, ss.127 - 194.
AMA Karatoy Erdem B,AKBAŞ S D Vitamini Ve Metabolomik. Türk Klinik Biyokimya Dergisi. 2018; 16(2): 127 - 194.
Vancouver Karatoy Erdem B,AKBAŞ S D Vitamini Ve Metabolomik. Türk Klinik Biyokimya Dergisi. 2018; 16(2): 127 - 194.
IEEE Karatoy Erdem B,AKBAŞ S "D Vitamini Ve Metabolomik." Türk Klinik Biyokimya Dergisi, 16, ss.127 - 194, 2018.
ISNAD Karatoy Erdem, Bilge - AKBAŞ, SADIKA HALİDE. "D Vitamini Ve Metabolomik". Türk Klinik Biyokimya Dergisi 16/2 (2018), 127-194.